CRISPR-Cas9 for large-scale engineering

This article describes the role of genome editing to CRISPR-Cas9 Ribonucleoproteins to engineer extracellular nanoparticles.

Related Keywords

Maria Osipova ,Maxcyte Inc Apr ,Maxcyte Inc ,Nature Communications ,Sponsored Content ,Inc Apr ,Maxcyte Flow ,Flow Electroporation ,Content Policy ,News Medical Net ,Crispr Cas9 ,Arge Scale Engineering ,Xtracellular Nanoparticles ,Nanomedic ,